Plenary Lectures Series
| For the full Scientific Program, please click here > |
| Plenary Lectures Series | Multiple Sclerosis | Epilepsy | Dementia |
| Headache | Stroke | Rehabilitation | Neuropsychiatry |
| Portuguese Amyloid Neuropathy | OPMD |
|
|||||
|
09:00-10:30 |
PLENARY LECTURES |
||||
|
|
Chairs: Amos D. Korczyn, Israel; Victor Oliveira, Portugal |
||||
| 09:00-09:30 | Welcome remarks Congress chairs |
||||
| 09:30-10:00 | Egas Moniz and his role in 20th century neurology Victor Oliveira, Portugal |
||||
| 10:00-10:30 | Polyglutamine disorders: More than simple repeats Sandra Macedo-Ribeiro, Portugal |
||||
| 10:30-11:00 | Coffee Break | ||||
| 11:00-13:00 | PLENARY LECTURES ON STROKE | ||||
| Chairs: Paula Moreira, Portugal; Virgilio Bento, Portugal | |||||
| 11:00-11:30 | Hysteria, simulation and functional disorders: From Charcot to Charcot? Julien Bogousslavsky, Switzerland |
||||
| 11:30-12:00 | Shifting the paradigm in brain protection and recovery Dafin Muresanu, Romania |
||||
| 12:00-12:30 | Role of exosomes/miRNA in mediating recovery after stroke and traumatic brain injury Michael Chopp, USA |
||||
| 12:30-13:00 | Post-stroke cerebral reorganization Jay P. Mohr, USA |
||||
| 13:00-13:45 | Lunch Break | ||||
| 13:45-15:15 | PLENARY LECTURES | ||||
| Chair: George Chakhava, Georgia | |||||
| 13:45-14:15 | Can the brain be really understood? Richard Frackowiak, Switzerland |
||||
| 14:15-14:45 | Vagus nerve stimulation: Headache and beyond Stephen Silberstein, USA |
||||
| 14:45-15:15 | Redefining neurological diseases through epigenetics Tiago Fleming Outeiro, Germany |
||||
| 15:15-15:30 | Coffee Break | ||||
| 15:30-18:00 | PLENARY LECTURES ON ALZHEIMER'S DISEASE | ||||
| Chairs: Daniel Ferreira, Sweden | |||||
| 15:30-16:00 | Alzheimer's disease: Organelles or proteins? Stavros Baloyannis, Greece |
||||
| 16:00-16:30 | Can Alzheimer's disease be prevented? Miia Kivipelto, Sweden |
||||
| 16:30-17:00 | Is AD caused by viral infection? Ruth Itzhaki, UK |
||||
| 17:00-18:00 | Debate: Is beta-amyloid still a relevant target in AD therapy? | ||||
| 17:00-17:10 | Host: Michael Geschwind , USA | ||||
| 17:10-17:25 | Yes: Paulo Fontoura, Switzerland | ||||
| 17:25-17:40 | No: Amos Korczyn, Israel | ||||
| 17:40-18:00 | Discussion and rebuttals | ||||
| 18:00 | Welcome Reception | ||||
|
|||
|
10:00-11:30 |
LECTURES: OPMD |
||
|
|
Chairs: Gillian Bulter-Brown, France; Jean-Pierre Bouchard, Canada |
||
| 10:00-10:30 |
Molecular aging: A primary or secondary trigger in late onset myopathies? Vered Raz, The Netherlands |
||
| 10:30-11:00 | OPMD therapy progress Aida Abu-Baker, Canada |
||
| 11:00-11:30 | Close encounter on chromosome 14 Sergiu Blumen, Israel |
||
